Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer: Self-rated physiological effects and symptoms

Acta Oncologica

Volumn 39, Issue 8, 2000, Pages 959-968

  Nystedt, M ^a   Berglund, G ^a   Bolund, C ^a   Brandberg, Y ^a   Fornander, T ^a   Rutqvist, L E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GOSERELIN; TAMOXIFEN;

ADULT; ANXIETY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SIDE EFFECT; SWEATING; SYMPTOMATOLOGY; VAGINA DISCHARGE;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANXIETY; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DEPRESSION; FEMALE; GOSERELIN; HUMANS; MEMORY; MIDDLE AGED; PREMENOPAUSE; TAMOXIFEN; VAGINA; VASOMOTOR SYSTEM;

EID: 0034505127     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860050215945     Document Type: Conference Paper

References (38)

1. Ovarian ablation in early breast cancer: Overview of the randomized trials
2. New Hormones
3. Goserelin in premenopausal advanced breast cancer: Clinical and endocrine evaluation of responsive patients
4. Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: Results of a multicentric Italian study
5. Luteinising hormone-releasing hormone analogues - The rationale for adjuvant use in premenopausal women with early breast cancer
6. Zoladex® and tamoxifen as adjuvant therapy in premenopausal breast cancer: A randomised trial by the Cancer Research Campaign (C.R.C.) Breast Cancer Trials Group, the Stockholm Breast Cancer Study Group, The South-East Sweden Breast Cancer Group & the Gruppo Interdisciplinare Valutazione Interventi in Oncologia (G.I.V.I.O.)
7. Effect of chemohormonal therapy in premenopausal, node (+), receptor (+) breast cancer: An Eastern Cooperative Oncology Group Phase III Intergroup Trial (E5188. INT-0101)
8. Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: Four-year results of Austrian Breast Cancer Study Group (ABCSG) Trial 5
9. Tamoxifen for early breast cancer: An overview of the randomized trials
10. Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer
11. Cardiac and thromboembolic morbidity among postmenopausal women with early-staged breast cancer in a randomized trial of adjuvant tamoxifen
12. Sexual functioning in women with breast cancer after treatment with adjuvant therapy
13. Menopause: A problem for breast cancer patients
14. Natural menopause and ovarian toxicity associated with breast cancer therapy
15. The prevalence of hot flash and associated variables among perimenopausal women
16. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: A population-based study
17. Predictors of menopausal symptoms: Psychosocial aspects
18. Use of tamoxifen for breast cancer: Twenty-eight years later. Review article
19. Five versus more than five years of tamoxifen therapy for breast cancer patients with node-negative lymph nodes and estrogen receptor-positive tumours
20. The prevalence of menopausal symptoms in patients treated for breast cancer
21. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning
22. The Royal Marsden Hospital pilot tamoxifen chemoprevention trial
23. A randomized study to compare the effect of luteinising hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer
24. The Sickness Impact Profile: Development and final revision of a health status measure
25. The Nottingham Health Profile: Subjective health status and medical consultations
26. Measuring the quality of life of cancer patients: The Functional Living Index - Cancer: Development and validation
27. Living with cancer: The cancer inventory of problem situations
28. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients
29. The hospital anxiety and depression scale
30. International experiences with the hospital anxiety and depression scale - A review of validation data and clinical results
31. Swedish obese subjects (SOS) - An intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined
32. Anxiety and depressive symptoms at different stages of malignant melanoma
33. Factor analysis, causal indicators and quality of life
34. Quality of life questionnaires in cancer clinical trials: Imputing missing values
35. Special paper. Methological and statistical issues of quality of life and economic evaluation in cancer clinical trials: Report of a workshop
36. The European organization for research and treatment of cuncer approach to quality of life assessment: Guidelines for developing questionnaire modules